Endophytic fungal species Nigrospora oryzae and Alternaria alternata exhibit antimicrobial activity against gram-positive and gram-negative multi-drug resistant clinical bacterial isolates
Authors:
Open Access
- 15 September 2023
- journal article
- research article
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 23 (1) , 1-13
Abstract
Background: The emergence of multidrug-resistant pathogens and the lack of new antimicrobial drugs is a major public health concern that needs urgent and innovative solutions. Endophytic fungi living in unique niches such as in endosymbiosis with plants are increasingly drawing attention as alternative sources of novel and chemically diverse compounds with unique mechanisms of action. Methods: In the present study, ten endophytic fungi isolated from the medicinal plant, Sclerocarya birrea were screened for bioactivity against a panel of indicator bacteria. Three bioactive endophytic fungi (strains P02PL2, P02MS1, and P02MS2A) were selected and identified through ITS-rDNA sequencing. The whole broth extracts of the three selected isolates were further screened against contemporary drug-resistant bacterial pathogens. This was followed by partial purification by solid phase extraction and GC–MS analysis of bioactive fractions. Results: The bioactive endophytic fungi were identified as Alternaria alternata species (strains P02PL2 and P02MS1) and Nigrospora oryzae (strain P02MS2A). The whole broth extracts from N. oryzae P02MS2A exhibited a MIC of one μg/mL and 16 μg/mL against gram-negative, MDR Pseudomonas 5625574 and gram-positive MRSA 25775 clinical isolates, respectively. After partial purification and GC–MS analysis of whole broth extract from A. alternaria PO2MS1, 2-fluorobenzoic acid heptadecyl was putatively identified as the active compound in fraction C of this extract. This compound was also putatively identified in fraction E of A. alternata P02PL2, fraction B of A. alternata P02MS1 and fraction B of N. oryzae P02MS2A, and interestingly, all these fractions retained activity against the two MDR clinical isolates. Conclusion: The putative identification of 2-fluorobenzoic acid heptadecyl compound showing a broad-spectrum of activity, more especially against gram-negative MDR contemporary pathogens is highly encouraging in the initiative at developing novel drugs to combat multi-drug resistance.Keywords
Funding Information
- National Research Foundation South Africa (129778)
This publication has 63 references indexed in Scilit:
- GC-MS analysis of bioactive compounds from the whole plant ethanolic extract of Evolvulus alsinoides (L.) LJournal of Food Science and Technology, 2013
- Lovastatin Production byAspergillus terreusUsing Agro-Biomass as Substrate in Solid State FermentationJournal of Biomedicine and Biotechnology, 2012
- Antimicrobial activity and constituents of the hexane extracts from leaf and stem of Origanum vulgare L. ssp. Viride (Boiss.) Hayek. growing wild in Northwest IranJournal of Medicinal Plants Research, 2012
- Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for FungiProceedings of the National Academy of Sciences of the United States of America, 2012
- Fifty years of drug discovery from fungiFungal Diversity, 2011
- Aging: An important factor for the pathogenesis of neurodegenerative diseasesMechanisms of Ageing and Development, 2009
- Sordarin, an antifungal agent with a unique mode of actionBeilstein Journal of Organic Chemistry, 2008
- Shape-persistent macrocycle with intraannular alkyl groups: some structural limits of discotic liquid crystals with an inverted structureBeilstein Journal of Organic Chemistry, 2008
- Chemical composition and antimicrobial activity of volatile components from capitula and aerial parts of Rhaponticum acaule DC growing wild in TunisiaMicrobiological Research, 2008
- A Sensitive and Quick Microplate Method to Determine the Minimal Inhibitory Concentration of Plant Extracts for BacteriaPlanta Medica, 1998